Literature DB >> 19616531

Positive correlation between galactose-1-phosphate uridyltransferase (GALT) and UDP-galactose-4'-epimerase (GALE) activities.

Irena Prodan-Zitnik1, Natasa Karas-Kuzelicki, Jana Lukac-Bajalo.   

Abstract

OBJECTIVES: The aim of our study was to determine whether the activities of galactose-1-phosphate uridyltransferase and UDP-galactose-4'-epimerase are correlated, and in what way they may influence one another. DESIGN AND METHODS: Enzyme activities were measured in red blood cells from 214 individuals.
RESULTS: A statistically significant (p<0.001) positive correlation was observed between GALT and GALE activities.
CONCLUSIONS: Our results suggest that GALT and GALE activities are correlated and that GALE activity has a greater impact on GALT activity than vice versa.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616531     DOI: 10.1016/j.clinbiochem.2009.07.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  3 in total

1.  Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models.

Authors:  Patricia P Jumbo-Lucioni; William M Parkinson; Danielle L Kopke; Kendal Broadie
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150

Review 2.  Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.

Authors:  Minela Haskovic; Ana I Coelho; Jörgen Bierau; Jo M Vanoevelen; Laura K M Steinbusch; Luc J I Zimmermann; Eduardo Villamor-Martinez; Gerard T Berry; M Estela Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2020-01-14       Impact factor: 4.982

3.  UDP-Glucose 4-Epimerase and β-1,4-Galactosyltransferase from the Oyster Magallana gigas as Valuable Biocatalysts for the Production of Galactosylated Products.

Authors:  Hui-Bo Song; Meng He; Zhi-Peng Cai; Kun Huang; Sabine L Flitsch; Li Liu; Josef Voglmeir
Journal:  Int J Mol Sci       Date:  2018-05-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.